market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Alphabet, the most common co-covered peer. Each carries 4 original sources on average. We currently track 1 Healthcare story that mention BMO Private Wealth, all published on August 20, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about BMO Private Wealth
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Alphabet, the most common co-covered peer. Each carries 4 original sources on average. We currently track 1 Healthcare story that mention BMO Private Wealth, all published on August 20, 2026.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering BMO Private Wealth. Shared-story counts are live from our verified record — not editorial picks.
Moderna's mRNA cancer therapy readout sent its shares up as much as 177%, driving a 2.9% record gain in the S&P 500 healthcare sector amid easing Treasury yields. The rally lifted peers including Merck, BioNTech and Novavax, but macro rate worries persist.